North Star Investment Management Corp. grew its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 22.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 95,842 shares of the company’s stock after buying an additional 17,501 shares during the period. North Star Investment Management Corp.’s holdings in PetMed Express were worth $4,361,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of PETS. Prudential Financial Inc. grew its stake in shares of PetMed Express by 552.8% in the 3rd quarter. Prudential Financial Inc. now owns 824,434 shares of the company’s stock worth $27,330,000 after buying an additional 698,140 shares in the last quarter. Old Mutual Global Investors UK Ltd. purchased a new position in shares of PetMed Express in the 3rd quarter worth $9,900,000. Vanguard Group Inc. grew its stake in shares of PetMed Express by 21.0% in the 2nd quarter. Vanguard Group Inc. now owns 1,300,725 shares of the company’s stock worth $52,810,000 after buying an additional 225,474 shares in the last quarter. Koch Industries Inc. purchased a new position in shares of PetMed Express in the 2nd quarter worth $212,000. Finally, Uniplan Investment Counsel Inc. grew its stake in shares of PetMed Express by 76.9% in the 3rd quarter. Uniplan Investment Counsel Inc. now owns 333,220 shares of the company’s stock worth $11,046,000 after buying an additional 144,903 shares in the last quarter. 99.88% of the stock is owned by institutional investors and hedge funds.

In related news, Director Ronald J. Korn sold 1,000 shares of PetMed Express stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $35.57, for a total transaction of $35,570.00. Following the completion of the sale, the director now owns 73,833 shares in the company, valued at approximately $2,626,239.81. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Gian Fulgoni sold 20,000 shares of PetMed Express stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $44.38, for a total transaction of $887,600.00. Following the sale, the director now owns 55,900 shares of the company’s stock, valued at approximately $2,480,842. The disclosure for this sale can be found here. 4.00% of the stock is currently owned by insiders.

PETS has been the subject of a number of recent analyst reports. Credit Suisse Group reaffirmed an “underperform” rating and set a $19.00 price target on shares of PetMed Express in a research note on Monday, October 2nd. ValuEngine cut shares of PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Zacks Investment Research cut shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. Northcoast Research set a $58.00 price target on shares of PetMed Express and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. Finally, BidaskClub raised shares of PetMed Express from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 9th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $42.80.

PetMed Express, Inc. (NASDAQ:PETS) traded up $1.04 during mid-day trading on Thursday, hitting $49.66. 273,900 shares of the company were exchanged, compared to its average volume of 470,557. PetMed Express, Inc. has a 52-week low of $19.21 and a 52-week high of $50.90. The stock has a market cap of $1,060.00, a PE ratio of 33.33, a PEG ratio of 2.87 and a beta of 1.12.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings results on Monday, October 23rd. The company reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The firm had revenue of $66.70 million during the quarter, compared to analysts’ expectations of $63.41 million. During the same period in the previous year, the company earned $0.24 EPS. The firm’s revenue for the quarter was up 9.7% compared to the same quarter last year. analysts anticipate that PetMed Express, Inc. will post 1.68 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “North Star Investment Management Corp. Acquires 17,501 Shares of PetMed Express, Inc. (PETS)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2018/01/11/north-star-investment-management-corp-acquires-17501-shares-of-petmed-express-inc-pets.html.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS).

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Stock Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related stocks with our FREE daily email newsletter.